Postdexamethason intact and multisequentia ACTH in melancholia

Area of Science:

• Neuroendocrinology
• Psychiatry
• Clinical Biochemistry

Background:

• The dexamethasone suppression test (DST) is a diagnostic tool for depression.
• HPA axis dysregulation, including cortisol and ACTH levels, is implicated in melancholic depression.

Purpose of the Study:

• To investigate cortisol and adrenocorticotropic hormone (ACTH) levels following dexamethasone administration in depressed inpatients.
• To determine the clinical relevance of different ACTH assays (multisequential vs. intact) in relation to depression severity and cortisol suppression.

Main Methods:

• 111 depressed inpatients underwent DST with 1 mg dexamethasone.
• Fasting 8 a.m. plasma cortisol and ACTH levels were measured pre- and post-dexamethasone.
• Intact (1-39) ACTH and multisequential (1-17, 1-24, 1-39) ACTH were analyzed in subgroups.

Main Results:

• Patients with melancholia showed significantly higher post-dexamethasone cortisol and intact ACTH compared to other depressive subtypes.
• Illness severity positively correlated with post-dexamethasone intact ACTH.
• Cortisol nonsuppressors had higher post-dexamethasone intact ACTH than suppressors.
• Both ACTH forms correlated positively with post-dexamethasone cortisol.

Conclusions:

• Cortisol nonsuppression in melancholia is attributed to augmented ACTH escape from dexamethasone suppression.
• Intact ACTH demonstrated the most significant clinical relevance for depression and cortisol nonsuppression.
• Post-dexamethasone intact ACTH is recommended over plasma cortisol or multisequential ACTH in clinical practice for depression assessment.